Amplifon 

$47.56
364
+$0.00+0%Friday 17:00

Statistics

Day High
47.56
Day Low
47.56
52W High
90.08
52W Low
46.58
Volume
100
Avg. Volume
0
Mkt Cap
12.92B
P/E Ratio
-
Dividend Yield
0.07%
Dividend
0.03

Upcoming

Dividends

0.07%Dividend Yield
Sep 2026
$0.02
Apr 2026
$0.01
Sep 2025
$0.01
Apr 2025
$0.01
Sep 2024
$0.01
10Y Growth
-16.51%
5Y Growth
N/A
3Y Growth
1.84%
1Y Growth
79.68%

Earnings

Oct 29Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
0.03
0.09
0.14
0.2
Expected EPS
0.0910289351522304
Actual EPS
0.0891446556452064

Financials

3.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.76BRevenue
104.35MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMFPY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GN Store Nord A.S.
GNNDY
Mkt Cap2.03B
GN Store Nord operates in the hearing aid industry through its subsidiary GN Hearing, directly competing with Amplifon in the hearing aid retail and distribution market.
Wegener
WGNR
Mkt Cap460,956
Widex + Sivantos (WS Audiology) is a major player in the hearing aid manufacturing and distribution sector, competing with Amplifon in providing hearing solutions globally.
Sonos
SONO
Mkt Cap1.91B
Sonova Holding AG is a leading manufacturer of hearing care solutions, offering products that compete with Amplifon's offerings in the hearing aid and audiological services market.
Deme Group N.V.
DEMGF
Mkt Cap0
Demant A/S, formerly known as William Demant Holding, is a global company in hearing healthcare that competes with Amplifon in hearing aids, audiometric equipment, and personal communication.
Solana
HSDT
Mkt Cap136.07M
Helius Medical Technologies, Inc. focuses on neurological wellness and its products could indirectly compete with Amplifon by offering alternative treatments for hearing-related conditions.
Inmode
INMD
Mkt Cap760.73M
InMode Ltd. is known for medical devices in different areas, including ear, nose, and throat (ENT), which could position it as a competitor in the broader market for hearing health solutions.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc, while known for its medical devices across various fields, has ventures in ENT that could indirectly compete with Amplifon in providing healthcare solutions for hearing.
Siemens
SIEGY
Mkt Cap239.92B
Siemens AG, through its audiology solutions and healthcare division, competes in the hearing aid market, offering products that could rival Amplifon's hearing solutions.
Koninklijke Philips N.V.
PHG
Mkt Cap26.31B
Koninklijke Philips N.V. operates in the health technology sector and has a broad portfolio that could encompass hearing health solutions, potentially competing with Amplifon in the healthcare market.

About

AMP Limited operates as a prominent wealth management enterprise, serving clients across Australia and internationally. The company's operations are divided into several key segments: Australian Wealth Management (AWM), AMP Bank, AMP Capital, and New Zealand Wealth Management. Within Australia, the AWM division delivers diverse financial services, including advisory, retirement income planning, and managed investment products, alongside superannuation, investment, and retirement solutions for both individual consumers and corporate entities; it also provides financial guidance and equity investment opportunities. AMP Bank primarily focuses on residential mortgages, deposit products, and transaction banking, with a strategic emphasis on technological advancements. Meanwhile, AMP Capital offers a broad spectrum of investment funds covering real estate, equities, fixed interest, and various diversified, multi-manager, and multi-asset strategies. In New Zealand, the wealth management segment provides comprehensive solutions such as KiwiSaver, corporate superannuation, and retail investment products, in addition to managing a sophisticated wrap investment platform. Founded in 1849, AMP Limited is based in Sydney, Australia.
Show More
CEO
Blair Robert Vernon
Employees
2275
Country
Australia
ISIN
US0321121040

Listings

0 Comments

Share your thoughts

FAQs

What is Amplifon stock price today?▼
The current price of AMFPY is $47.56 USD — it has increased by +0% in the past 24 hours. Watch Amplifon stock price performance more closely on the chart.
What is Amplifon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Amplifon stocks are traded under the ticker AMFPY.
Is Amplifon stock price growing?▼
AMFPY stock has risen by +0% compared to the previous week, the month change is a +1.91% rise, over the last year Amplifon has showed a -32.32% decrease.
What is Amplifon market cap?▼
Today Amplifon has the market capitalization of 12.92B
When is the next Amplifon earnings date?▼
Amplifon is going to release the next earnings report on March 10, 2027.
What were Amplifon earnings last quarter?▼
AMFPY earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.1 USD resulting in a -2.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Amplifon revenue for the last year?▼
Amplifon revenue for the last year amounts to 2.76B USD.
What is Amplifon net income for the last year?▼
AMFPY net income for the last year is 104.35M USD.
Does Amplifon pay dividends?▼
Yes, AMFPY dividends are paid annual. The last dividend per share was 1.35 . As of today, Dividend Yield (FWD)% is 0.07%.
How many employees does Amplifon have?▼
As of November 7, 2026, the company has 2,275 employees.
In which sector is Amplifon located?▼
Amplifon operates in the Finance & Payments sector.
When did Amplifon complete a stock split?▼
The last stock split for Amplifon was on May 8, 2006 with a ratio of 10:1.
Where is Amplifon headquartered?▼
Amplifon is headquartered in Sydney, Australia.